RxDoctor Payments Data

Michael Kiselev, MD

Anesthesiology · New York, NYNPI 1982737003

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 31.4% of the total. 2025 is the largest year on record at $986, more than ten times the $66 reported in 2021. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,331in general payments, 2019–2025

Across 104 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$733
  • Johnson & Johnson$637
  • AbbVie$308
  • Celltrion USA Inc.$179
  • Lilly USA, LLC$178
  • QOL Medical, LLC$81
  • plus $216 from 6 others

What the payments were for

  • Food & beverage$2,29999%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,331 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York →

Medicare billing

Part B allowed, 2024
$47,469
Medicare patients
506
Services billed
517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →